239 related articles for article (PubMed ID: 28297622)
1. Clinical Trials in the Genomic Era.
Joffe E; Iasonos A; Younes A
J Clin Oncol; 2017 Mar; 35(9):1011-1017. PubMed ID: 28297622
[TBL] [Abstract][Full Text] [Related]
2. Integration of cancer genomics with treatment selection: from the genome to predictive biomarkers.
Ow TJ; Sandulache VC; Skinner HD; Myers JN
Cancer; 2013 Nov; 119(22):3914-28. PubMed ID: 24037788
[TBL] [Abstract][Full Text] [Related]
3. Personalized Medicine: Genomics Trials in Oncology.
Hayes DF; Schott AF
Trans Am Clin Climatol Assoc; 2015; 126():133-43. PubMed ID: 26330667
[TBL] [Abstract][Full Text] [Related]
4. Rationale and study design of the CardioGene Study: genomics of in-stent restenosis.
Ganesh SK; Skelding KA; Mehta L; O'Neill K; Joo J; Zheng G; Goldstein J; Simari R; Billings E; Geller NL; Holmes D; O'Neill WW; Nabel EG
Pharmacogenomics; 2004 Oct; 5(7):952-1004. PubMed ID: 15469413
[TBL] [Abstract][Full Text] [Related]
5. Feasibility of Large-Scale Genomic Testing to Facilitate Enrollment Onto Genomically Matched Clinical Trials.
Meric-Bernstam F; Brusco L; Shaw K; Horombe C; Kopetz S; Davies MA; Routbort M; Piha-Paul SA; Janku F; Ueno N; Hong D; De Groot J; Ravi V; Li Y; Luthra R; Patel K; Broaddus R; Mendelsohn J; Mills GB
J Clin Oncol; 2015 Sep; 33(25):2753-62. PubMed ID: 26014291
[TBL] [Abstract][Full Text] [Related]
6. Precision oncology: A new era of cancer clinical trials.
Renfro LA; An MW; Mandrekar SJ
Cancer Lett; 2017 Feb; 387():121-126. PubMed ID: 26987624
[TBL] [Abstract][Full Text] [Related]
7. The use of genomics in clinical trial design.
Simon R
Clin Cancer Res; 2008 Oct; 14(19):5984-93. PubMed ID: 18829477
[TBL] [Abstract][Full Text] [Related]
8. National Cancer Institute's Precision Medicine Initiatives for the new National Clinical Trials Network.
Abrams J; Conley B; Mooney M; Zwiebel J; Chen A; Welch JJ; Takebe N; Malik S; McShane L; Korn E; Williams M; Staudt L; Doroshow J
Am Soc Clin Oncol Educ Book; 2014; ():71-6. PubMed ID: 24857062
[TBL] [Abstract][Full Text] [Related]
9. Statistical controversies in clinical research: basket trials, umbrella trials, and other master protocols: a review and examples.
Renfro LA; Sargent DJ
Ann Oncol; 2017 Jan; 28(1):34-43. PubMed ID: 28177494
[TBL] [Abstract][Full Text] [Related]
10. Designing transformative clinical trials in the cancer genome era.
Sleijfer S; Bogaerts J; Siu LL
J Clin Oncol; 2013 May; 31(15):1834-41. PubMed ID: 23589555
[TBL] [Abstract][Full Text] [Related]
11. Basket Studies: Redefining Clinical Trials in the Era of Genome-Driven Oncology.
Tao JJ; Schram AM; Hyman DM
Annu Rev Med; 2018 Jan; 69():319-331. PubMed ID: 29120700
[TBL] [Abstract][Full Text] [Related]
12. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
13. How Imaging Biomarkers Can Inform Clinical Trials and Clinical Practice in the Era of Targeted Cancer Therapy.
Farwell MD; Clark AS; Mankoff DA
JAMA Oncol; 2015 Jul; 1(4):421-2. PubMed ID: 26181243
[No Abstract] [Full Text] [Related]
14. The landscape of precision cancer medicine clinical trials in the United States.
Roper N; Stensland KD; Hendricks R; Galsky MD
Cancer Treat Rev; 2015 May; 41(5):385-90. PubMed ID: 25864024
[TBL] [Abstract][Full Text] [Related]
15. MarkVCID cerebral small vessel consortium: I. Enrollment, clinical, fluid protocols.
Wilcock D; Jicha G; Blacker D; Albert MS; D'Orazio LM; Elahi FM; Fornage M; Hinman JD; Knoefel J; Kramer J; Kryscio RJ; Lamar M; Moghekar A; Prestopnik J; Ringman JM; Rosenberg G; Sagare A; Satizabal CL; Schneider J; Seshadri S; Sur S; Tracy RP; Yasar S; Williams V; Singh H; Mazina L; Helmer KG; Corriveau RA; Schwab K; Kivisäkk P; Greenberg SM;
Alzheimers Dement; 2021 Apr; 17(4):704-715. PubMed ID: 33480172
[TBL] [Abstract][Full Text] [Related]
16. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
17. Clinical Trial Accrual Targeting Genomic Alterations After Next-Generation Sequencing at a Non-National Cancer Institute-Designated Cancer Program.
Mantripragada KC; Olszewski AJ; Schumacher A; Perez K; Birnbaum A; Reagan JL; Mega A; Khurshid H; Bartley C; Lombardo A; Rossiter R; Papa A; Bakalarski P; Safran H
J Oncol Pract; 2016 Apr; 12(4):e396-404. PubMed ID: 26907448
[TBL] [Abstract][Full Text] [Related]
18. Clinical trial design in the era of precision medicine.
Fountzilas E; Tsimberidou AM; Vo HH; Kurzrock R
Genome Med; 2022 Aug; 14(1):101. PubMed ID: 36045401
[TBL] [Abstract][Full Text] [Related]
19. Clinical research in small genomically stratified patient populations.
Martin-Liberal J; Rodon J
Eur J Cancer; 2017 Jul; 80():73-82. PubMed ID: 28591680
[TBL] [Abstract][Full Text] [Related]
20. Database of genomic biomarkers for cancer drugs and clinical targetability in solid tumors.
Dienstmann R; Jang IS; Bot B; Friend S; Guinney J
Cancer Discov; 2015 Feb; 5(2):118-23. PubMed ID: 25656898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
